MARAVAI LIFESCIENCES HOLDINGS, INC. 8-K

What Happened
Maravai LifeSciences Holdings, Inc. (MRVI) announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025 in a press release dated February 25, 2026. The company furnished the full press release as Exhibit 99.1 to its Form 8-K filed February 25, 2026; the report was signed by Chief Financial Officer Rajesh Asarpota. The Form 8-K was filed under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Date filed: February 25, 2026; reporting period: quarter and full fiscal year ended December 31, 2025.
• Press release containing the financial results is furnished as Exhibit 99.1 to the Form 8-K.
• Exhibit 99.1 is furnished (not “filed”) and is not automatically subject to certain Exchange Act liabilities or incorporated by reference into other filings unless specifically stated.
• The filing was signed by CFO Rajesh Asarpota.

Why It Matters
Earnings releases and Form 8-K disclosures are the primary way a company communicates quarterly and yearly performance to investors. This filing signals Maravai has publicly reported its Q4 and full-year 2025 results; investors should read the attached press release (Exhibit 99.1) or the company’s earnings presentation for the detailed revenue, profit, guidance, and other metrics that could affect the stock price and investment decisions.